| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |